News
Two final-year students at the Kwame Nkrumah University of Science and Technology (KNUST) have developed an innovative, ...
The team has been awarded a $2.5 million grant to develop a system for inserting tiny light-emitting fibers directly into ...
Soligenix (NASDAQ: SNGX) is spotlighting new interim data on HyBryte(TM) (synthetic hypericin) for early-stage cutaneous T-cell ly ...
12h
BBC Good Food on MSNWhat is psoriasis?Learn all about psoriasis, a chronic inflammatory disease, including common symptoms, treatments, plus which diet and ...
As hair health gains traction in beauty, Cosmetics Business investigates why the scalp is finally getting the attention it ...
The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results